CJC-1295 (NO DAC)+IPAMORELIN
$160.00
This dual-peptide formulation is engineered for advanced laboratory research into growth hormone–releasing pathways. It combines CJC-1295 (No DAC), a short-acting GHRH analogue, with Ipamorelin, a selective Growth Hormone Releasing Peptide (GHRP), providing complementary support for GH secretion and cellular signalling in controlled experimental conditions. Supplied in a pharmaceutical-grade, lyophilised format, this synergistic blend ensures exceptional purity, solubility, and reproducibility for precise research applications.
Each vial is produced in a GMP-compliant, ISO-certified facility and independently verified through HPLC and LC-MS testing to confirm ≥99% purity, molecular structure, and composition. The formulations are trusted for consistency, accuracy, and reliability, delivering dependable performance across a wide range of peptide research studies.
Technical Specifications
- Composition: CJC-1295 No DAC (5 mg) + Ipamorelin (5 mg)
- Purity: ≥ 99 % (independently verified)
- Solubility: Fully soluble in water (H₂O)
- Use: Designed for growth hormone, receptor-binding, and peptide signalling research
Product Disclaimer
This compound is intended strictly for laboratory and research purposes. It is not designed for human consumption, medical, or therapeutic use. By purchasing, you confirm that you are a qualified researcher handling this material responsibly and in full compliance with all relevant safety regulations.
Storage
Keep sealed and stored dry at 2–8 °C. Once reconstituted, refrigerate and use within 6 weeks.
